RELMADA THERAPEUTICS, INC. — Director's Dealing 2015

Mar 5, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RELMADA THERAPEUTICS, INC. (RLMD)
CIK: 0001553643
Period of Report: 2015-02-23

Reporting Person: BECK DOUGLAS (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-23	Options to purchase common stock	$2.70	A	25000	Acquired	2025-02-23	Common stock (25000)	Direct

Footnotes

F1: Pursuant to the terms of the company's 2014 Stock Option and Equity Incentive Plan, 6.25% of the options shall vest each quarter from the date of grant.

F2: Includes (i) options to purchase an aggregate of 334,199 shares of Common Stock of the Company, 104,437 shares of Common Stock will have vested within 60 days of March 5, 2015, and (ii) options to purchase an aggregate of 25,000 shares of Common Stock of the Company, 0 shares of Common Stock will have vested within 60 days of March 5, 2015.